Natalizumab Injection Suppliers & Bulk Manufacturers
Available Forms: IV Injection
Available Strengths: 300 mg
Reference Brands: Tysabri(US & EU)
Category:
Multiple sclerosis
Natalizumab is a monoclonal antibody that blocks α4-integrin, preventing immune cells from crossing the blood-brain barrier. It reduces inflammation, decreases MS relapses, and slows disease progression. Benefits include effective disease control, fewer relapses, and improved quality of life for patients with relapsing multiple sclerosis.
Natalizumab injection is available in IV Injection
and strengths such as 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Natalizumab injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Natalizumab injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Natalizumab injection, marketed as Tysabri, is approved in the US by the FDA and in the EU via EMA for multiple sclerosis and Crohn’s disease. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and safety data, while the EMA ensures compliance with regional safety and quality standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing